Guardian Pharmacy CEO gifts 200,000 shares to donor-advised fund

Guardian Pharmacy Services reported an insider stock gift by its President, Chief Executive Officer and Director.

Rhea-AI Filing Summary

Guardian Pharmacy Services reported an insider stock gift by its President, Chief Executive Officer and Director. On 12/04/2025, the reporting person made a bona fide gift of 200,000 shares of Class A common stock, coded as a gift transaction, at a reported price of $0 per share.

The shares were donated to a charitable donor-advised fund, which agreed not to sell or transfer the shares during a lock-up period that expires on June 30, 2026, and to hold the shares in its account for up to three years from the gift date. After this transaction, the reporting person beneficially owned 1,511,845 shares of Class A common stock, held directly.

Insider Trade Summary

200,000 shares gifted

Gift 1 txn

Insider Burke Fred

Role See Remarks

Type	Security	Shares	Price	Value
Gift	Class A Common Stock	200,000	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 1,511,845 shares (Direct)

Footnotes (1)

1. F1. Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund (the "DAF"). The DAF has agreed (i) not to sell or transfer the shares during a lock-up period expiring June 30, 2026, and (ii) to hold the shares in its account for up to three years from the gift date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Guardian Pharmacy Services (GRDN) report?

Guardian Pharmacy Services reported that its President, Chief Executive Officer and Director made a bona fide gift of 200,000 shares of Class A common stock on 12/04/2025, as shown on a Form 4.

Who received the 200,000 gifted GRDN shares?

The 200,000 shares of Guardian Pharmacy Services Class A common stock were gifted to a charitable donor-advised fund, referred to as the DAF.

Are the gifted Guardian Pharmacy Services (GRDN) shares subject to a lock-up?

Yes. The donor-advised fund agreed not to sell or transfer the shares during a lock-up period that expires on June 30, 2026.

How long will the donor-advised fund hold the gifted GRDN shares?

The donor-advised fund agreed to hold the shares in its account for up to three years from the 12/04/2025 gift date.

How many Guardian Pharmacy Services (GRDN) shares does the insider own after the gift?

Following the reported gift transaction, the reporting person beneficially owned 1,511,845 shares of Guardian Pharmacy Services Class A common stock, held directly.

What is the insider’s role at Guardian Pharmacy Services (GRDN)?

The reporting person is a Director and an Officer, serving as President and Chief Executive Officer of Guardian Pharmacy Services, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 04:10 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burke Fred

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/04/2025		G		200,000(1)	D	$0	1,511,845	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund (the "DAF"). The DAF has agreed (i) not to sell or transfer the shares during a lock-up period expiring June 30, 2026, and (ii) to hold the shares in its account for up to three years from the gift date.

Remarks:

President and Chief Executive Officer

	/s/ Douglas Towns, Attorney-in-Fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.